期刊文献+

糖尿病大鼠坐骨神经calpainⅡ的动态表达

CalpainⅡexpression in sciatic nerves of diabetic rats
下载PDF
导出
摘要 目的观察早期糖尿病(DM)大鼠坐骨神经calpainⅡ的动态表达,探讨其在糖尿病多发性神经病(DPN)发病中的作用。方法以链佐星(STZ)诱导DM大鼠模型,通过原位杂交和免疫组化技术观察不同病程DM大鼠坐骨神经calpainⅡmRNA和蛋白的表达;并通过光镜和电镜观察坐骨神经形态,免疫组化观察坐骨神经中神经丝(NF)的表达。结果DM4和8周大鼠坐骨神经calpainⅡmRNA均较正常组明显减少[(2.64±0.78)%vs(5.44±0.36)%,P<0.001;(1.97±0.31)%vs(5.18±0.69)%,P<0.001];蛋白表达也较正常组明显减少[(3.35±0.57)%vs(7.79±1.42)%,P<0.001;(2.82±0.77)%vs(6.47±1.12)%,P<0.001]。DM4周时坐骨神经仅有超微结构改变,NF含量无明显改变;DM8周时神经形态明显改变,NF含量明显减少。结论DM大鼠坐骨神经calpainⅡ表达减少,其参与DPN的发病。 Purpose To observe the expressions of calpainI] in sciatic nerves of diabetic rats,and its implication in the pathogenesis of diabetic polyneuropathy(DPN). Methods Diabetes mellitus(DM) were induced by single intraperitoneal injection of strepzocin (STZ). The expressions of calpain Ⅱ mR- NA and protein in sciatic nerve of DM in 4 weeks or 8 weeks rats were observed by in situ hybridization and immunohistochemistry. Morphological findings were also observed under light and electron microscopy, and neurofilament (NF) expression was detected by immunohistochemistry. Results Calpain Ⅱ mRNA expressions were reduced significantly both in DM 4 weeks [(2. 64 ± 0. 78)% vs (5.44 ± 0.36) % ,P〈0, 001] and bM 8 weeks [(1.97 ± 0.31) % -as (5.18 ± 0.69) %, P〈0. 001)] rats. CalpainlI protein were also decreased significantly in DM 4 weeks [(3.35 ± 0.57) % vs (7.79 ± 1, 42) % ,P 〈0. 001)] and DM 8 weeks [(2.82 ± 0.77)% vs (6.47 ± 1.12) % ,P〈0. 001)]. At DM 4 weeks, only ultrastructural lesions was observed, NF expression did not changed. At DM 8 weeks, morphological abnormalities were obvious, and NF expression was decreased. Conclusions Calpain Ⅱ expressions were decreased in the sciatic nerves of DM rats, which may be involved in the pathogenesis of DPN.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2006年第1期1-5,共5页 Fudan University Journal of Medical Sciences
关键词 糖尿病 坐骨神经 神经病理 calpainⅡ 神经丝 diabetes mellitus sciatic nerve nerve pathology calpainⅡ neurofilament
  • 相关文献

参考文献21

  • 1.糖尿病性神经病变[M].蒋雨平.临床神经疾病学[C].上海:上海医科大学出版社,1999.470.
  • 2Mata M, Kupina N, Fink DJ. Calpain Ⅱ in rat peripheral nerve[J]. Brain Res, 1991,564(2):328.
  • 3Li Z, Banik NL. The localization of mcalpain in myelin: immunocytochemical evidence in different-areas of rat brain and nerves[J]. Brain Res, 1995,697(1-2): 112.
  • 4Shields DC, Leblanc C, Banik NL. Calcium-mediated neurofilament protein degradation in rat optic nerve in vitro: activity and autolysis of calpain proenzyme[J]. Exp Eye Res,1997,65(1): 15.
  • 5Castejon MS, Culver DG, Glass JD. Generation of spectrin breakdown products in peripheral nerves by addition of M-calpain[J]. Muscle Nerve, 1999,22(7):905.
  • 6Banik NL, Shields DC, Ray S, et al. Role of calpainin spinal cord injury; effects of ealpain and free radical inhibitors[J].Ann N Y Acad Sci , 1998,844:131.
  • 7Li Z, Hogan EL, Banik NL. Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat spinal cord after impact trauma[J]. Neurochem Res, 1996,21 (4):441.
  • 8Glass JD, Culver DG, Levey AI, et al. Very early activation of m-calpain in peripheral nerve during Wallerian degeneration[J]. J Neurol Sci, 2002,196(1-2):9.
  • 9Calcutt NA, Dines KC, Cessena RM. Effects of the peptide HP228 on nerve disorders in diabetic rats[J]. Metabolism,1998,147:650.
  • 10张云云,蒋雨平,乔凯,张玉林,任惠民.糖尿病大鼠神经功能、形态和半乳糖神经酰胺转移酶的变化[J].复旦学报(医学版),2003,30(3):211-214. 被引量:12

二级参考文献13

  • 1Bosio A, Binczek E, Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc Natl Acad Sci USA, 1996,12,93(23): 13280
  • 2Bosio A, Bussow H, Adam J. Galactosphingolipids and axono-glial interaction in myelin of the central nervous system. Cell Tissue Res, 1998,292:199
  • 3Dupree JL, Coetzee T, Suzuki K, et al. Myelin abnormalities in mice deficient in galactocerebroside and sulfatide. J Neurocytol,1998,27(9) :649
  • 4Kalichman MW, Dines KC, Bobik M, et al. Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin. Brain Res, 1998,810:130
  • 5Calcutt NA, Dines KC, Cessena RM. Effects of the peptide HP228on nerve disorders in diabetic rats. Metabolism, 1998,147: 650
  • 6Alichman MW, Powell HC, Mizisin AP. Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol ( Berl ), 1998,95(1):47
  • 7Jurevics H, Hostettler J, Muse ED, et al. Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain. J Neurochem, 2001,77 (4):1067
  • 8Toews AD, Roe EB, Goodrum JF, et al. Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression.Brain Res Mol Brain Res, 1997,3,49 ( 1 - 2):113
  • 9Conti AM, Scarpini E, Malosio ML, et al. In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy. Neurosci Lett, 1996,207 (1): 65
  • 10Stahl N,Jurevics H, Morell P, et al. Isolation, characterization, and expression of cDNA clones that encode rat UDP-galactose: ceramide galactosyltransferase. J Neurosci Res, 1994,38 (2):234

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部